Kaitlyn Arsenault

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kaitlyn Arsenault
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kaitlyn Arsenault:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Chief Financial Officer Common Stock 167,522 $835,935 $4.99 18 Nov 2024 Direct
Skye Bioscience, Inc. Chief Financial Officer Stock Option (Right to Buy) 150,000 $2,125 $0.0170 24 Feb 2025 Direct

Insider Reports Filed by Kaitlyn Arsenault

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 24 Feb 2025 1 $0 4 Chief Financial Officer 26 Feb 2025, 17:53
SKYE Skye Bioscience, Inc. 15 Nov 2024 2 -$215,754 4/A Chief Financial Officer 28 Feb 2025, 18:54
SKYE Skye Bioscience, Inc. 28 Oct 2024 1 $0 4 Chief Financial Officer 30 Oct 2024, 20:32
SKYE Skye Bioscience, Inc. 29 Feb 2024 2 $0 4/A Chief Financial Officer 04 Mar 2024, 06:15
SKYE Skye Bioscience, Inc. 29 Feb 2024 2 $0 4 Chief Financial Officer 01 Mar 2024, 18:42
SKYE Skye Bioscience, Inc. 06 Nov 2023 2 $0 4 Chief Financial Officer 06 Nov 2023, 20:29
SKYE Skye Bioscience, Inc. 25 Aug 2023 2 $0 4 Chief Financial Officer 29 Aug 2023, 19:53
SKYE Skye Bioscience, Inc. 14 Dec 2021 2 $0 4 Chief Financial Officer 16 Dec 2021, 17:59
SKYE Skye Bioscience, Inc. 04 Oct 2021 1 $0 4 Chief Financial Officer 05 Oct 2021, 20:42
SKYE Skye Bioscience, Inc. 04 Oct 2021 0 $0 3 Chief Financial Officer 05 Oct 2021, 20:40